• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Phastar Appoints Chris Schoonmaker as Chief Operations Officer

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Shimadzu Scientific Instruments Extends HQ Campus

    Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills

    Batavia Enters Commercial Manufacturing Business

    CoreRx Expands Capabilities

    Pierre Fabre and Lonza Enter Manufacturing Agreement
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate

    MasterControl and Elemental Machines Form Biomanufacturing Partnership

    Charles River and Ziphius Vaccines to Manufacture saRNA-based Vaccine
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Qosina

    Baxter BioPharma Solutions

    Quotient Sciences

    Biosynth Carbosynth

    IDT Biologika
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Qosina

    Baxter BioPharma Solutions

    Quotient Sciences

    Biosynth Carbosynth

    IDT Biologika
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    How to Balance Internal and External Staff Within Outsourcing Models

    Strategies to consider in flexed staffing models.

    How to Balance Internal and External Staff Within Outsourcing Models
    Related CONTENT
    • Embedding Your Drug Strategy Within a Solid Foundation for Success
    • Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm
    • QTS Medical Device Outsourcing
    • Pii Gets Registered as a Part of the FDA’s 503B Solution
    • Advanced Analytical Features Services
    John Barry, SVP, Consulting Practice and Chief Strategy Officer, PRA Health Sciences, SSD09.22.20
    Today, many pharma and biotech companies are moving away from the traditional “all in” and “all out” staffing models where roles were either fully outsourced or sourced entirely from the company’s internal capabilities. Traditional “all in” models create the risk of stranded or under-utilized resources. An “all out” model solves that problem, but at the expense of losing the internal competence of the role.

    To solve for these challenges, many companies are turning to flexed staffing models which maintain some of the internal competence for a role while avoiding the risk of overstaffing internally. A flexed staffing model is one where the resources to satisfy a particular role competence are provided by a blend of customer and supplier resources. For example, 30% of the clinical research associate (CRA) roles at an organization might be staffed by internal employees, while the remaining 70% are supplier-based (non-employee) resources. This ultimately results in a lower cost to deliver the portfolio delivery while at the same time minimizing and mitigating possible co-employment risks.  

    One question still remains: What is the right level of internal and external staff?

    Consider the flex ratio.

    What is a flex ratio?
    Historically, pharma companies that went through operating model transformations often considered a role as either 100% internally staffed or 100% outsourced. This was done as a way to create a more flexible workforce and to ensure the co-employment risk was well-managed.

    This strategy presents a unique challenge for the customer as they lose all internal access to the particular role that has been outsourced. Because of this, we’ve recently seen companies change their strategy and begin rebuilding some internal capabilities. Now, many companies have a mixed model approach, with a portion of their workforce sourced as employees and the remainder sourced by suppliers. That’s where the flex ratio comes into play.

    The flex ratio is simply the proportion of external staff as a percentage of the total. For example, a flex ratio of 80% means that eight out of ten staff are sourced externally and only two are actual customer employees. A variable flex ratio attempts to formulaically determine the right level of internal and external staff for each particular sponsor. Each role is assigned a variable flex ratio based on the key criteria below. The flex ratio percentage determines the percent of staff out (outsourced from a CRO) or in (employees). This moves the sponsor from a staff augmentation model to a resource management model and begins to include some provisioning of infrastructure support from the supplier.

    What is the right level of internal and external staff?
    Based on five general principles, we can derive a flex ratio for any role under consideration:

    •    Knowledge Investment
    It’s important to measure the knowledge-based investment made by a company into a resource. These investments include things like training, continuing education, and leadership development, and can be quite expensive. If an employee leaves or is reassigned, knowledge investments made by the sponsor become a sunk cost to the company. The higher this investment, the more likely the company will want to retain the staff, which is easier to control when they are employees. On the contrary, highly administrative roles that require less knowledge investment will have a higher flex ratio and therefore be outsourced more frequently than roles that require a significantly higher knowledge investment.

    Bottom line: The higher the knowledge investment, the lower the flex ratio.

    •    Scale
    When determining a flex ratio, we must also consider the total number of resources required, or the scale. Scale affects the flex ratio for two main reasons. The larger the scale, the more likely that the competence itself is not a core competence or is not difficult to access externally. A large workforce of employees does not necessarily create a competitive advantage.

    More importantly, the higher the scale, the higher the risk of stranded resources if the development portfolio reduces or shifts its geographic focus. Many decision-makers ask, “What happens when the company grows?” However, they often neglect to address what happens when the company doesn’t.

    Bottom line: The larger the scale, the higher the flex ratio.

    •    Duration to Available
    How long it takes for a resource to be made available is another factor to consider in a highly competitive resource market. For example, securing a CRA may take less time than finding an MD—this time is an investment. The longer it takes to find someone to fill a role, the more likely it is that the organization will want to protect that investment. That’s easier to do with an employee than it is to “rent” that competence from a supplier.

    Bottom line: The longer it takes to find and secure an employee, the lower the flex ratio.

    •    Knowledge Dependence
    It’s also critical to measure the difference between tacit and explicit knowledge. Generally, people have tacit knowledge. This is what drives relationships. The more a role’s effectiveness depends on managing a relationship, the lower the flex ratio. Likewise, explicit knowledge is in the process of the system, not necessarily the people. For process-driven roles such as many found in data management, it’s possible to change staff members without losing process knowledge. Therefore, explicit knowledge dependence equates to a much higher flex ratio.

    Bottom line: The more tacit knowledge is required for a role, the lower the flex ratio. The more the role will depend on explicit knowledge, the higher the flex ratio.

    •    Competitive Advantage
    Does “owning” the resource create a competitive advantage for the company? For example, an organization would likely prefer to have a pioneering scientist who discovers a new immunotherapy candidate as an employee so that they could protect this knowledge capital. The same might be said for a thought leader whose name and expertise a company wants to be associated with.

    Bottom line: The higher the competitive advantage, the lower the flex ratio.

    So, how exactly does the flex formula work?
    To determine the “right” flex ratio for a sponsor, the above considerations can be weighted and scored based on the sponsor’s priorities. As the role-based flex ratio is determined, it’s important to balance the competing risks. A higher flex ratio may increase risk related to ownership and accountability, higher turnover, and the loss of a functional role as a core competence. On the other hand, a lower flex ratio may increase risk related to stranded resources, performance management, access to the appropriate resource, and portfolio ebbs and flows.

    Flex Ratio Criteria Table: The Flex Formula1


    Applying the Formula
    When we use a Likert scale (or similar) and apply the formula, the above example yields the following flex ratio results:


     

     
    We find the benefits of these flexed models usually outweigh the risks. The variable flex ratio allows you to manage co-employment risks, stranded resource risk, and maximize returns on people investments. Unlike the traditional “all in” and “all out” staffing models which strike an imbalance in risk management, the flexed model manages these risks more effectively. Working with an experienced CRO that embeds its own staff within your functional portfolio can help you to assess, manage, and mitigate many co-employment risks that may exist within traditional staffing approaches.



    John Barry serves as the SVP and Chief Strategy Officer for PRA’s Strategic Solutions Division. In this role, John is responsible for managing the division’s consulting practice and providing strategic oversight on key opportunities and customer models. John has extensive experience in the drug development industry and has worked as an executive leader in a variety of functions including alliance management, business development, clinical operations, contracts, proposals, and legal. Prior to joining PRA, John was the COO at a mid-size CRO, after 4 years as head of portfolio sourcing and relationship management and a member of the senior leadership team for Merck Research Laboratories’ Global Clinical Trials Organization. Prior to joining Merck, John spent over 20 years working for two of the top five global CROs.
    Related Searches
    • Drug Development
    • Clinical Trials
    Suggested For You
    Embedding Your Drug Strategy Within a Solid Foundation for Success Embedding Your Drug Strategy Within a Solid Foundation for Success
    Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm
    QTS Medical Device Outsourcing QTS Medical Device Outsourcing
    Pii Gets Registered as a Part of the FDA’s 503B Solution Pii Gets Registered as a Part of the FDA’s 503B Solution
    Advanced Analytical Features Services Advanced Analytical Features Services
    Federal Equipment Federal Equipment's Adam Covitt
    JML Consulting Group JML Consulting Group

    Related Content

    • Drug Development
      Embedding Your Drug Strategy Within a Solid Foundation for Success

      Embedding Your Drug Strategy Within a Solid Foundation for Success

      This whitepaper looks at the broad set of trends influencing pharmaceutical development and manufacturing strategy today.

    • Clinical Trials | Drug Development
      Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm

      Pharma’s Imperative: Rethinking the FSP Outsourcing Paradigm

      Evaluating outsourcing strategies amid a complex trial landscape to further enhance clinical operations.
      Michael D. Jones , Vice President of Clinical FSP Client Engagement, IQVIA 08.17.20

    • QTS Medical Device Outsourcing

      QTS Medical Device Outsourcing

      ...
      Sarah Thomas, Marketing Communications Specialist 07.22.20


    • Pii Gets Registered as a Part of the FDA’s 503B Solution

      Pii Gets Registered as a Part of the FDA’s 503B Solution

      Added to the list of organizations officially registered as human drug outsourcing facilities.
      Contract Pharma Staff 07.06.20

    • Advanced Analytical Features Services

      Advanced Analytical Features Services

      Michelle Gonzalez, Client Services Specialist, spoke exclusively with Contract Pharma at Contracting & Outsourcing 2018
      Contract Pharma Staff

      Loading, Please Wait..
      Trending
      • Regulatory Report: Analytical Procedure Development
      • Pierre Fabre And Lonza Enter Manufacturing Agreement
      • Pfizer, BioNTech Adapt COVID Vax Against Omicron
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Shimadzu Scientific Instruments Extends HQ Campus
      Breaking News
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      • Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      • EQT Private Equity Acquires SPT Labtech from Battery Ventures
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Kensing Acquires Vitae Naturals
      CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
      Shiitake Mushroom Extract Appears Helpful in HPV Infections
      Coatings World

      Latest Breaking News From Coatings World

      Sheboygan Paint Company Adds Rosey Malchow as Customer Experience Manager
      PPG to Announce Second Quarter 2022 Results July 21
      Evonik Unveils Range of Sustainable Liquid Polybutadienes
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Researchers Develop New Apparatus for the Treatment of Cardiovascular Diseases
      NovaXS Unveils New Prototype of Needle-Free Injection Therapy Smart Medical Device
      Meddux Opens New Facility in Boulder, Colorado
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK
      EQT Private Equity Acquires SPT Labtech from Battery Ventures
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Highlights from Paris Packaging Week
      Walgreens Boots Alliance Decides Not to Sell Boots and No7 Beauty Company Businesses
      WWP Beauty Unveils New Packaging Collections in Collaboration with Eastman
      Happi

      Latest Breaking News From Happi

      Evonik Holds Groundbreaking Ceremony for Commercial Rhamnolipid Production Facility
      CHT USA Hosts Groundbreaking Ceremony for $20 Million US Headquarters Expansion
      Azelis Expands Global Flavors & Fragrances Platform with Acquisition in India
      Ink World

      Latest Breaking News From Ink World

      Temporary Content Title
      Amcor Lift-Off Initiative Shortlists Start-ups for Seed Funding
      Barentz Highlights Lincoln MFG’s New ISO 9001:2015 Certification
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Sibress launches FADS3D flexo plate measuring device
      Mike Brown appointed VP for Davis-Standard’s Canadian operations
      Constantia Flexibles introduces chemical resistant recycle-ready laminate
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Suominen Launches Hydraspun Reserve
      Richard Knowlson Receives Lifetime Technical Achievement Award
      Skylark Launches Thicker Label Closure Technology in North American
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Tecomet Appoints Bill Dow as President & CEO
      Medacta, InSilicoTrials Partner on Orthopedic Device Development
      Researchers Develop Microfluidic Sensors to Improve Implant Survival Rates
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Avery Dennison Launches New Dual-Frequency RFID Inlay
      Avery Dennison Highlights New Approach to Apparel with ADX Lab
      trinamiX Face Authentication Protects Users from Fraud Attacks During Mobile Payments

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login